Asterias Provides 24 Month Cohort 2 Update for its OPC1 Phase 1/2a Clinical Trial in Severe Spinal Cord Injury
Asterias Biotherapeutics Announces New Exclusive License Agreement with The Regents of the University of California
Red Metal's Carrizal IP Survey Defines a Chargeability Trend Across All Six Consecutive Lines, Open at Depth
Spartan Metals Expands Past-Producing Tungstonia Mine Mineralization Footprint More Than 13-Fold, Defining 5.7 km2 of Tungsten-Silver Veins with Assays up to 5.18% WO3
